MedTrace Logo

Intrathecal Morphine for Inguinal Hernia Repair.

NCT02001948 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2013-12-05

No results posted yet for this study

Summary

The aim of this study was to compare the effects of two different doses of intrathecal morphine (0.1 mg and 0.4 mg) combined with 7.5 mg of heavy bupivacaine on postoperative block regression times, postoperative analgesia and the severity of side effects, for inguinal hernia repairs.

Conditions

Interventions

DRUG

intrathecal morphine 0.1 mg combined with intrathecal heavy bupivacaine 7.5 mg

DRUG

intrathecal morphine 0.4 mg combined with intrathecal heavy bupivacaine 7.5 mg

DEVICE

standard monitoring with Datex Ohmeda anesthesia monitor, GE, Finland

electrocardiography, heart rate, pulse oximetry and noninvasive arterial blood pressure

DRUG

intravenous cannulation and premedication

18-gauge intravenous cannula was inserted at the forearm opposite to the surgical side and routine iv premedication (midazolam 0.03 mg/kg) was given

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Principal Investigators

  • Basak Ceyda Meco · Ankara University Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02001948 on ClinicalTrials.gov